In line with Future Market Insights (FMI) research, the global Network Point Of Care Glucose Testing Industry is set to achieve a significant value, reaching US$ 1.6 billion in 2021 and is projected to soar to US$ 2.5 billion by 2032. This robust growth is substantiated by the data showing that revenue from Accu-Chek Inform II experienced a steady compound annual growth rate (CAGR) of 4.5% from 2017 to 2021. The exceptional popularity of Accu-Chek Inform II can be attributed to its cutting-edge automatic real-time wireless capabilities, facilitating seamless and precise patient data transmission between healthcare professionals and laboratories. Furthermore, the system boasts advanced features, including individualized patient identification, ensuring error-free and personalized care.
Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-15860
US to Dominate Network Point-Of-Care Glucose Testing Market throughout the Analysis Period
In 2021, the United States generated the most revenue in the network point-of-care glucose testing market. In the United States, revenue from network point-of-glucose testing increased at a 4.6% CAGR from 2017 to 2021. The high prevalence of diabetes in the geriatric population, combined with increased awareness of glucose testing, is driving the network point-of-care glucose testing market in the United States. Furthermore, with key companies taking the lead in raising awareness about POC glucose monitoring, the market is expected to grow by US$ 735 million by 2032.
Network Point-Of-Care Glucose Testing Market: Competition Insights
Companies engaged in network point-of-care glucose testing are solely concerned with raising diabetes awareness and developing advanced point-of-care glucose testing devices. F. Hoffmann-La Roche and others are key players in the network point-of-care glucose testing market. The company Hoffmann-La Roche Ltd. Danaher, Abbott, Nipro, Platinum Equity Advisors, LLC (Lifescan, Inc.), Nova Biomedical, ACON Laboratories, Trividia Health, Inc., Prodigy Diabetes Care, LLC, Bayer AG/Ascensia Diabetes Care Holdings AG, EKF Diagnostics, and others are among the companies that have participated.
Examining the core assumptions of the study. Ask an Analyst
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15860
Some of the recent developments by key providers of Network Point-of-Care Glucose Testing are as follows:
- Roche announced the release of the Cobas pulse system in January 2022 to manage blood glucose solutions. It is intended to be the first diagnostic tool available at the point of care, as well as a means for users to communicate with developers of digital health software and applications. As a result, clinical insights will become easier to obtain, and patient care will improve.
- EKF Diagnostics introduced the STAT-Site WB handheld analyzer in October 2021. It is primarily used for determining -ketone and glucose levels in whole blood in seconds. It sends results in 10 seconds for -ketones and 5 seconds for glucose using two different test strips.
- EKF Diagnostics will collaborate with Tosoh Europe N.V. in May 2020. for the Middle East and Africa distribution of a Quo-Test HbA1c point-of-care (POC) analyzer The collaboration’s goal is to meet the needs of those who are more likely to develop diabetes.
- ACON laboratories released an On Call Express Voice in the US market in September 2019. This feature complements ACON laboratories’ family of blood glucose metres. It includes navigation and an audio feature to help the user get the most out of the audible blood glucose metre.
Key Segments Covered in Network Point-of-Care Glucose Testing Industry Survey
Network Point-of-Care Glucose Testing Market by Product Type:
- i-STAT
- Accu-Chek Inform II
- Stat Strip
- Hemo Cue
- Care Sens Expert Plus
- BARO-zen H Expert Plus
Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/15860
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Network Point of Care Glucose Testing Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of Product Type (i-STAT, Accu-Chek Inform II, Stat Strip, Hemo Cue, Care Sens Expert Plus, BARO-zen H Expert Plus), across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube